Related references
Note: Only part of the references are listed.Mass spectrometry-based targeted proteomics for analysis of protein mutations
Tai-Tu Lin et al.
MASS SPECTROMETRY REVIEWS (2023)
SAAMBE-SEQ: a sequence-based method for predicting mutation effect on protein-protein binding affinity
Gen Li et al.
BIOINFORMATICS (2021)
Multifunctionality of prostatic acid phosphatase in prostate cancer pathogenesis
Evgenia Alpert et al.
BIOSCIENCE REPORTS (2021)
Bioinformatic analysis of dysregulated proteins in prostate cancer patients reveals putative urinary biomarkers and key biological pathways
Tania Lima et al.
MEDICAL ONCOLOGY (2021)
The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2021)
Clinicopathological and prognostic significance of osteopontin expression in patients with prostate cancer: a systematic review and meta-analysis
Anze Yu et al.
BIOSCIENCE REPORTS (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
TGF-β Signaling and Resistance to Cancer Therapy
Maoduo Zhang et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights
Zhiqiang Pang et al.
NUCLEIC ACIDS RESEARCH (2021)
Association of Urinary MyProstateScore, Age, and Prostate Volume in a Longitudinal Cohort of Healthy Men: Long-term Findings from the Olmsted County Study
Jeffrey J. Tosoian et al.
EUROPEAN UROLOGY OPEN SCIENCE (2021)
Biomarkers for prostate cancer: prostate-specific antigen and beyond
Michael J. Duffy
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2020)
The DisGeNET knowledge platform for disease genomics: 2019 update
Janet Pinero et al.
NUCLEIC ACIDS RESEARCH (2020)
Pan-cancer mapping of differential protein-protein interactions
Gizem Gulfidan et al.
SCIENTIFIC REPORTS (2020)
GSTP1 rs1138272 Polymorphism Affects Prostate Cancer Risk
Veljko Santric et al.
MEDICINA-LITHUANIA (2020)
Targeted Mass Spectrometry of a Clinically Relevant PSA Variant from Post-DRE Urines for Quantitation and Genotype Determination
Joseph J. Otto et al.
PROTEOMICS CLINICAL APPLICATIONS (2020)
The disruption of protein-protein interactions as a therapeutic strategy for prostate cancer
Barbara Matos et al.
PHARMACOLOGICAL RESEARCH (2020)
The Proteogenomic Landscape of Curable Prostate Cancer
Ankit Sinha et al.
CANCER CELL (2019)
Prostatic Acid Phosphatase (PAP) Predicts Prostate Cancer Progress in a Population-Based Study: The Renewal of PAP?
Huan Xu et al.
DISEASE MARKERS (2019)
Construction of prognostic microRNA signature for human invasive breast cancer by integrated analysis
Wei Shi et al.
ONCOTARGETS AND THERAPY (2019)
Protein biomarker discovery is still relevant and has entered a new phase
Yuri E. M. van der Burgt
EBIOMEDICINE (2019)
E-cadherin is downregulated in benign prostatic hyperplasia and required for tight junction formation and permeability barrier in the prostatic epithelial cell monolayer
Feng Li et al.
PROSTATE (2019)
Proteogenomic Analysis of Protein Sequence Alterations in Breast Cancer Cells
Iulia M. Lazar et al.
SCIENTIFIC REPORTS (2019)
The Role of Membrane Bound Complement Regulatory Proteins in Tumor Development and Cancer Immunotherapy
Anne Geller et al.
FRONTIERS IN IMMUNOLOGY (2019)
Screening, identification of prostate cancer urinary biomarkers and verification of important spots
Huijun Zhao et al.
INVESTIGATIONAL NEW DRUGS (2019)
The PRIDE database and related tools and resources in 2019: improving support for quantification data
Yasset Perez-Riverol et al.
NUCLEIC ACIDS RESEARCH (2019)
Approaches to urinary detection of prostate cancer
Jillian N. Eskra et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2019)
Comparative Proteome Profiling and Mutant Protein Identification in Metastatic Prostate Cancer Cells by Quantitative Mass Spectrometry-based Proteogenomics
Oh Kwang Kwon et al.
CANCER GENOMICS & PROTEOMICS (2019)
Relationship between inter-α-trypsin inhibitor heavy chain 4 and ovarian cancer
Min Huang et al.
CHINESE JOURNAL OF CANCER RESEARCH (2019)
Comparative Secretome Profiling and Mutant Protein Identification in Metastatic Prostate Cancer Cells by Quantitative Mass Spectrometry-based Proteomics
Oh Kwang Kwon et al.
CANCER GENOMICS & PROTEOMICS (2018)
Glutathione transferases: substrates, inihibitors and pro-drugs in cancer and neurodegenerative diseases
Nerino Allocati et al.
ONCOGENESIS (2018)
Beyond the Role of CD55 as a Complement Component
So Hee Dho et al.
IMMUNE NETWORK (2018)
Underexpression of α-1-microglobulin/bikunin precursor predicts a poor prognosis in oral squamous cell carcinoma
Shoichi Sekikawa et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2018)
Tissue proteomics outlines AGR2 AND LOX5 as markers for biochemical recurrence of prostate cancer
Giovanny Rodríguez-Blanco et al.
Oncotarget (2018)
Comparative Proteomics Analysis of Urine Reveals Down-Regulation of Acute Phase Response Signaling and LXR/RXR Activation Pathways in Prostate Cancer
Katarina Davalieva et al.
PROTEOMES (2018)
Epidermal Growth Factor-Containing Fibulin-Like Extracellular Matrix Protein 1 (EFEMP1) Acts as a Potential Diagnostic Biomarker for Prostate Cancer
Hao Shen et al.
MEDICAL SCIENCE MONITOR (2017)
Proteomic analysis of urinary extracellular vesicles from high Gleason score prostate cancer
Kazutoshi Fujita et al.
SCIENTIFIC REPORTS (2017)
A comprehensive analysis and annotation of human normal urinary proteome
Mindi Zhao et al.
SCIENTIFIC REPORTS (2017)
Prostate-derived ets factor represses tumorigenesis and modulates epithelial-to-mesenchymal transition in bladder carcinoma cells
Ke-Hung Tsui et al.
CANCER LETTERS (2016)
Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker-Based Risk Score
Leander Van Neste et al.
EUROPEAN UROLOGY (2016)
Adaptor Protein CD2AP and L-type Lectin LMAN2 Regulate Exosome Cargo Protein Trafficking through the Golgi Complex
Sang-Ho Kwon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Association between BHMT gene rs3733890 polymorphism and cancer risk: evidence from a meta-analysis
Yue Xu et al.
ONCOTARGETS AND THERAPY (2016)
PSA and beyond: alternative prostate cancer biomarkers
Sharanjot Saini
CELLULAR ONCOLOGY (2016)
Perlecan/HSPG2 and matrilysin/MMP-7 as indices of tissue invasion: tissue localization and circulating perlecan fragments in a cohort of 288 radical prostatectomy patients
Brian Grindel et al.
ONCOTARGET (2016)
A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial Biopsy
James McKiernan et al.
JAMA ONCOLOGY (2016)
Novel biomarkers for the detection of prostate cancer
Niels Asger Jakobsen et al.
JOURNAL OF CLINICAL UROLOGY (2016)
Mining the Human Proteome Biomarker Discovery for Human Cancer and Metastases
Jiang Yang et al.
CANCER JOURNAL (2015)
Parafilm-assisted microdissection: a sampling method for mass spectrometry-based identification of differentially expressed prostate cancer protein biomarkers
J. Quanico et al.
CHEMICAL COMMUNICATIONS (2015)
Development and Clinical Validation of an In Situ Biopsy-Based Multimarker Assay for Risk Stratification in Prostate Cancer
Peter Blume-Jensen et al.
CLINICAL CANCER RESEARCH (2015)
Immuno-based detection of extracellular vesicles in urine as diagnostic marker for prostate cancer
Diederick Duijvesz et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
sE-cadherin serves as a diagnostic and predictive parameter in prostate cancer patients
Igor Tsaur et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)
Transport proteins NHA1 and NHA2 are essential for survival, but have distinct transport modalities
Venkateswara R. Chintapalli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Proteomics analysis of urine reveals acute phase response proteins as candidate diagnostic biomarkers for prostate cancer
Katarina Davalieva et al.
PROTEOME SCIENCE (2015)
Targeting ECM disrupts cancer progression
Freja A. Venning et al.
FRONTIERS IN ONCOLOGY (2015)
Do prostate cancer risk models improve the predictive accuracy of PSA screening? A meta-analysis
K. S. Louie et al.
ANNALS OF ONCOLOGY (2015)
Associations of vitamin D pathway genes with circulating 25-hydroxyvitamin-D, 1,25-dihydroxyvitamin-D, and prostate cancer: a nested case-control study
Rebecca Gilbert et al.
CANCER CAUSES & CONTROL (2015)
Prostatic acid phosphatase expression in human tissues
Thomas J. Graddis et al.
CLINICAL CANCER RESEARCH (2015)
Epigenetic regulation of EFEMP1 in prostate cancer: biological relevance and clinical potential
Mafalda Almeida et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2014)
Proteogenomic characterization of human colon and rectal cancer
Bing Zhang et al.
NATURE (2014)
Associations Between SNPs Within Antioxidant Genes and the Risk of Prostate Cancer in the Siberian Region of Russia
N. A. Oskina et al.
PATHOLOGY & ONCOLOGY RESEARCH (2014)
TNFα-Mediated Loss of β-Catenin/E-Cadherin Association and Subsequent Increase in Cell Migration Is Partially Restored by NKX3.1 Expression in Prostate Cells
Bilge Debelec-Butuner et al.
PLOS ONE (2014)
Pursuing type 1 diabetes mellitus and related complications through urinary proteomics
Armando Caseiro et al.
TRANSLATIONAL RESEARCH (2014)
Oncogenic functions of IGF1R and INSR in prostate cancer include enhanced tumor growth, cell migration and angiogenesis
Isabel Heidegger et al.
ONCOTARGET (2014)
Urinary aHGF, IGFBP3 and OPN as diagnostic and prognostic biomarkers for prostate cancer
Alisa J. Prager et al.
BIOMARKERS IN MEDICINE (2013)
Acid ceramidase as a therapeutic target in metastatic prostate cancer
Luz Camacho et al.
JOURNAL OF LIPID RESEARCH (2013)
High level of serum AMBP is associated with poor response to paclitaxel-capecitabine chemotherapy in advanced gastric cancer patients
Hao Huang et al.
MEDICAL ONCOLOGY (2013)
Integrating Structure to Protein-Protein Interaction Networks That Drive Metastasis to Brain and Lung in Breast Cancer
H. Billur Engin et al.
PLOS ONE (2013)
Glutathione-S-transferase (GST) polymorphisms are associated with relapse after radical prostatectomy
J. Cotignola et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2013)
Zinc α2-glycoprotein as a potential novel urine biomarker for the early diagnosis of prostate cancer
Ioannis Katafigiotis et al.
BJU INTERNATIONAL (2012)
A gene signature identified using a mouse model of androgen receptor-dependent prostate cancer predicts biochemical relapse in human disease
Vanessa C. Thompson et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Identifying mutated proteins secreted by colon cancer cell lines using mass spectrometry
Suresh Mathivanan et al.
JOURNAL OF PROTEOMICS (2012)
Soluble E-cadherin and IL-6 serum levels in patients affected by prostate cancer before and after prostatectomy
Fortunata Iacopino et al.
ONCOLOGY REPORTS (2012)
A Fragment of the LG3 Peptide of Endorepellin Is Present in the Urine of Physically Active Mining Workers: A Potential Marker of Physical Activity
Tony J. Parker et al.
PLOS ONE (2012)
EFEMP1 as a Novel DNA Methylation Marker for Prostate Cancer: Array-Based DNA Methylation and Expression Profiling
Yong-June Kim et al.
CLINICAL CANCER RESEARCH (2011)
Fine mapping the KLK3 locus on chromosome 19q13.33 associated with prostate cancer susceptibility and PSA levels
Hemang Parikh et al.
HUMAN GENETICS (2011)
Identification of a novel prostate cancer susceptibility variant in the KLK3 gene transcript
Z. Kote-Jarai et al.
HUMAN GENETICS (2011)
Predicting the functional impact of protein mutations: application to cancer genomics
Boris Reva et al.
NUCLEIC ACIDS RESEARCH (2011)
ADAM17 (TACE) regulates TGFβ signaling through the cleavage of vasorin
J. Malapeira et al.
ONCOGENE (2011)
Quantitative Proteomic Profiling of Prostate Cancer Reveals a Role for miR-128 in Prostate Cancer
Amjad P. Khan et al.
MOLECULAR & CELLULAR PROTEOMICS (2010)
Glycan gene expression signatures in normal and malignant breast tissue; possible role in diagnosis and progression
Ivan O. Potapenko et al.
MOLECULAR ONCOLOGY (2010)
A method and server for predicting damaging missense mutations
Ivan A. Adzhubei et al.
NATURE METHODS (2010)
Genetic Correction of PSA Values Using Sequence Variants Associated with PSA Levels
Julius Gudmundsson et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Diverse Cell Signaling Events Modulated by Perlecan
John M. Whitelock et al.
BIOCHEMISTRY (2008)
Frequent expression loss of Inter-alpha-trypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors: A systematic expression analysis
Alexander Hamm et al.
BMC CANCER (2008)
Search for potential markers for prostate cancer diagnosis, prognosis and treatment in clinical tissue specimens using amine-specific isobaric tagging (iTRAQ) with two-dimensional liquid chromatography and tandem mass spectrometry
Spiros D. Garbis et al.
JOURNAL OF PROTEOME RESEARCH (2008)
PCA3: A molecular urine assay for predicting prostate biopsy outcome
Ina L. Deras et al.
JOURNAL OF UROLOGY (2008)
Identification of circulating endorepellin LG3 fragment: Potential use as a serological biomarker for breast cancer
Jong Wook Chang et al.
PROTEOMICS CLINICAL APPLICATIONS (2008)
Prostatic acid phosphatase adversely affects cause-specific survival in patients with intermediate to high-risk prostate cancer treated with Brachytherapy
L. Christine Fang et al.
UROLOGY (2008)
LC-MS/MS quantification of Zn-α2 glycoprotein:: A potential serum biomarker for prostate cancer
Olga P. Bondar et al.
CLINICAL CHEMISTRY (2007)
Endorepellin in vivo: Targeting the tumor vasculature and retarding cancer growth and metabolism
Gregory Bix et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Perlecan, a candidate gene for the CAPB locus, regulates prostate cancer cell growth via the Sonic Hedgehog pathway
Milton W. Datta et al.
MOLECULAR CANCER (2006)
Increased expression of osteopontin contributes to the progression of prostate cancer
AC Khodavirdi et al.
CANCER RESEARCH (2006)
In-gel digestion for mass spectrometric characterization of proteins and proteomes
Andrej Shevchenko et al.
NATURE PROTOCOLS (2006)
Inhibition of decay-accelerating factor (CD55) attenuates prostate cancer growth and survival in vivo
Robert D. Loberg et al.
NEOPLASIA (2006)
Suppression of prostate tumor cell growth by stromal cell prostaglandin D synthase-derived products
J Kim et al.
CANCER RESEARCH (2005)
Assessment of a fragment of e-cadherin as a serum biomarker with predictive value for prostate cancer
R Kuefer et al.
BRITISH JOURNAL OF CANCER (2005)
BMP-1/tolloid-like metalloproteases process endorepellin, the angiostatic C-terminal fragment of perlecan
EM Gonzalez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Perlecan knockdown in metastatic prostate cancer cells reduces heparin-binding growth factor responses in vitro and tumor growth in vivo
C Savore et al.
CLINICAL & EXPERIMENTAL METASTASIS (2005)
Insulin-like growth factor ligands, receptors, and binding proteins in cancer
E Foulstone et al.
JOURNAL OF PATHOLOGY (2005)
Zinc-α2-glycoprotein, a lipid mobilizing factor, is expressed in adipocytes and is up-regulated in mice with cancer cachexia
C Bing et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Proliferation of DU145 prostate cancer cells is inhibited by suppressing insulin-like growth factor binding protein-2
S Chatterjee et al.
INTERNATIONAL JOURNAL OF UROLOGY (2004)
Biologically active sphingolipids in cancer pathogenesis and treatment
B Ogretmen et al.
NATURE REVIEWS CANCER (2004)
Vasorin, a transforming growth factor β-binding protein expressed in vascular smooth muscle cells, modulates the arterial response to injury in vivo
Y Ikeda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
ITIH4 (inter-alpha-trypsin inhibitor heavy chain 4) is a new acute-phase protein isolated from cattle during experimental infection
M Piñeiro et al.
INFECTION AND IMMUNITY (2004)
Hypermethylation of the human glutathione S-transferase-π gene (GSTP1) CpG island is present in a subset of proliferative inflammatory atrophy lesions but not in normal or hyperplastic epithelium of the prostate -: A detailed study using laser-capture-microdissection
M Nakayama et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Suppression of invasion and peritoneal carcinomatosis of ovarian cancer cell line by overexpression of bikunin
M Suzuki et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan
M Mongiat et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Share Paper
